Advanced Search

Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2002 October;137(5) > Giornale Italiano di Dermatologia e Venereologia 2002 October;137(5):347-51

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014

Frequency: Bi-Monthly

ISSN 0392-0488

Online ISSN 1827-1820

 

Giornale Italiano di Dermatologia e Venereologia 2002 October;137(5):347-51

    CLINICAL CASES

D-penicillamine-induced elastosis perfornans serpiginosa

Pinna A. L. 1, Ambu R. 2, Atzori L. 1, Aste N. 1

1 Clinica Dermatologica Università degli Studi di Cagliari, Cagliari
2 I Cattedra Anatomia Patologica Università degli Studi di Cagliari, Cagliari

Elastosis Perforans Serpiginosa (EPS) is an uncommon skin disease characterized by transepithelial elimination of abnormal dermal elastic fibers. This disease can be divided into three forms: idiopathic EPS; EPS associated with specific genetic connective tissue defects and D-penicillamine induced EPS after prolonged high dose therapy for Wilson’s disease, cystinuria, rheumatoid arthritis. A 28 year-old man with Wilson’s disease since he was 18 years-old and since that under prolonged treatment with D-penicillamine, noted the onset, two years ago, of multiple keratotic papules in serpiginous and annular pattern along the neck and on the righ arm respectively. Examination of biopsy specimens by light microscopy revealed the characteristic changes of EPS both idiopathic and D-penicillamine induced. Examination by transmission electron microscopy revealed characteristic changes of the elastic fibers of the D-penicillamine induced EPS never up till now described in idiopathic EPS. D-penicillamine is a life saving drug in the treatment of Wilson’s disease, as a copper chelating agent, in spite of the well documented systemic and cutaneous unwanted effects produced. The pathogenic mechanism of the dermatopathy and how D-penicillamine induced the elastic fibers changes with their subsequent extrusion on the surface of the skin is unknown; some pathogenic hypotheses are suggested.

language: Italian


FULL TEXT  REPRINTS

top of page